Recent insights into the role of tumor Necrosis factor in the failing heartMANN, Douglas L.Heart failure reviews. 2001, Vol 6, Num 2, pp 71-80, issn 1382-4147Article

Inflammatory mediators and the failing heart: Past, present, and the foreseeable futureMANN, Douglas L.Circulation research. 2002, Vol 91, Num 11, pp 988-998, issn 0009-7330, 11 p.Article

The role of inflammatory mediators in the failing heartMANN, Douglas L.Heart failure reviews. 2001, Vol 6, Num 2, issn 1382-4147, 84 p.Serial Issue

MicroRNAs and the failing heartMANN, Douglas L.The New England journal of medicine. 2007, Vol 356, Num 25, pp 2644-2645, issn 0028-4793, 2 p.Article

Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: Has the time come for randomized clinical trials?MANN, Douglas L.Journal of the American College of Cardiology. 2001, Vol 38, Num 1, pp 184-186, issn 0735-1097Article

The Emerging Role of Small Non-coding RNAs in the Failing Heart: Big Hopes for Small MoleculesMANN, Douglas L.Cardiovascular drugs and therapy. 2011, Vol 25, Num 2, issn 0920-3206, p. 149Article

In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceSHAH, Ajay M; MANN, Douglas L.Lancet (British edition). 2011, Vol 378, Num 9792, pp 704-712, issn 0140-6736, 9 p.Article

Contemporary medical options for treating patients with heart failureKONSTAM, Marvin A; MANN, Douglas L.Circulation (New York, N.Y.). 2002, Vol 105, Num 19, pp 2244-2246, issn 0009-7322Article

The role of nitric oxide in the failing heartPAULUS, Walter J.Heart failure reviews. 2001, Vol 6, Num 2, pp 105-118, issn 1382-4147Article

Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?MANN, Douglas L; BARGER, Philip M; BURKHOFF, Daniel et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 24, pp 2465-2472, issn 0735-1097, 8 p.Article

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathwayKALRA, Dinesh; SIVASUBRAMANIAN, Natarajan; MANN, Douglas L et al.Circulation (New York, N.Y.). 2002, Vol 105, Num 18, pp 2198-2205, issn 0009-7322Article

The role of interleukin-1 in the failing heartLONG, Carlin S; MD.Heart failure reviews. 2001, Vol 6, Num 2, pp 81-94, issn 1382-4147Article

Role of MicroRNAs in Cardiac Remodeling and Heart FailureTOPKARA, Veli K; MANN, Douglas L.Cardiovascular drugs and therapy. 2011, Vol 25, Num 2, pp 171-182, issn 0920-3206, 12 p.Article

The role of inflammatory mediators in the failing heart : Immunomodulation of cytokines in experimental models of heart failureMATSUMORI, Akira; SASAYAMA, Shigetake.Heart failure reviews. 2001, Vol 6, Num 2, pp 129-136, issn 1382-4147Article

Targeted anticytokine therapy and the failing heartMANN, Douglas L.The American journal of cardiology. 2005, Vol 95, Num 11A, pp 9C-16C, issn 0002-9149Conference Paper

Effects of changes in left ventricular contractility on indexes of contractility in miceNEMOTO, Shintaro; DEFREITAS, Gilberto; MANN, Douglas L et al.American journal of physiology. Heart and circulatory physiology. 2002, Vol 52, Num 6, pp H2504-H2510, issn 0363-6135Article

Beneficial effects of the CorCap cardiac support device: Five-year results from the Acorn TrialMANN, Douglas L; KUBO, Spencer H; SABBAH, Hani N et al.Journal of thoracic and cardiovascular surgery (Print). 2012, Vol 143, Num 5, pp 1036-1042, issn 0022-5223, 7 p.Article

Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblastsLOVELOCK, Joshua D; BAKER, Andrew H; FENG GAO et al.American journal of physiology. Heart and circulatory physiology. 2005, Vol 57, Num 2, pp H461-H468, issn 0363-6135Article

Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved election fractionAGOSTON, Ildiko; CAMERON, Craig S; YAO, David et al.The American journal of cardiology. 2004, Vol 94, Num 8, pp 1003-1007, issn 0002-9149, 5 p.Article

Circulating levels of tumor necrosis factor correlate with indexes of depressed Heart rate variability: A study in Patients with mild-to-moderate heart failureMALAVE, Hector A; TAYLOR, Addison A; NATTAMA, Jaggarao et al.Chest. 2003, Vol 123, Num 3, pp 716-724, issn 0012-3692, 9 p.Article

Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitationORAL, Hakan; SIVASUBRAMANIAN, Natarajan; STARLING, Mark R et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 6, pp 831-837, issn 0009-7322, 7 p.Article

Brief murine myocardial I/R induces chemokines in a TNF-α-independent manner: role of oxygen radicalsNOSSULI, Tareck O; FRANGOGIANNIS, Nikolaos G; KNUEFERMANN, Pascal et al.American journal of physiology. Heart and circulatory physiology. 2001, Vol 50, Num 6, pp H2549-H2558, issn 0363-6135Article

Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failureTORRE-AMIONE, Guillermo; YOUNG, James B; DURAND, Jean-Bernard et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 7, pp 973-980, issn 0009-7322Conference Paper

Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes: A RELAX Trial Ancillary StudyLINDMAN, Brian R; DAVILA-ROMAN, Victor G; REDFIELD, Margaret M et al.Journal of the American College of Cardiology. 2014, Vol 64, Num 6, pp 541-549, issn 0735-1097, 9 p.Article

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical TrialREDFIELD, Margaret M; CHEN, Horng H; DESWAL, Anita et al.JAMA, the journal of the American Medical Association. 2013, Vol 309, Num 12, pp 1268-1277, issn 0098-7484, 10 p.Article